Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Stegall

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Journal of the American Society of Nephrology : JASN|December 26, 2023
Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney TransplantFlavio Vincenti, Oriol Bestard, Amarpali Brar, et al.
Journal of the American Society of Nephrology : JASN|June 23, 2019
Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical UseJean Kwun, Marie Matignon, Miriam Manook, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 12, 2024
Anti-HLA serologic response to CD38-targeting desensitization therapy is challenged by peripheral memory B cells in highly sensitized kidney transplant candidatesAlba Torija, Marie Matignon, Flavio Vincenti, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2021
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney FoundationAndrew S Bomback, Gerald B Appel, Debbie S Gipson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 6, 2023
The Banff 2022 Kidney Meeting Work Plan: Data-driven refinement of the Banff Classification for renal allograftsCandice Roufosse, Maarten Naesens, Mark Haas, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Journal of the American Society of Nephrology : JASN|December 26, 2023
Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney TransplantFlavio Vincenti, Oriol Bestard, Amarpali Brar, et al.
Journal of the American Society of Nephrology : JASN|June 23, 2019
Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical UseJean Kwun, Marie Matignon, Miriam Manook, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 12, 2024
Anti-HLA serologic response to CD38-targeting desensitization therapy is challenged by peripheral memory B cells in highly sensitized kidney transplant candidatesAlba Torija, Marie Matignon, Flavio Vincenti, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2021
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney FoundationAndrew S Bomback, Gerald B Appel, Debbie S Gipson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 6, 2023
The Banff 2022 Kidney Meeting Work Plan: Data-driven refinement of the Banff Classification for renal allograftsCandice Roufosse, Maarten Naesens, Mark Haas, et al.
Pageof 4